Tvardi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TVRD and other ETFs, options, and stocks.About TVRD
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
TVRD Key Statistics
Stock Snapshot
As of today, Tvardi Therapeutics(TVRD) shares are valued at $4.02. The company's market cap stands at 37.71M, with a P/E ratio of -0.41.
As of 2026-03-05, Tvardi Therapeutics(TVRD) stock has fluctuated between $3.92 and $4.10. The current price stands at $4.02, placing the stock +2.6% above today's low and -2.0% off the high.
Tvardi Therapeutics(TVRD) shares are trading with a volume of 13.72K, against a daily average of 42.11K.
During the past year, Tvardi Therapeutics(TVRD) stock moved between $3.50 at its lowest and $43.65 at its peak.
During the past year, Tvardi Therapeutics(TVRD) stock moved between $3.50 at its lowest and $43.65 at its peak.
Analyst ratings
50%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.